v3.26.1
SEGMENT INFORMATION - Schedule of Financial Information by Segment (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Segment Reporting [Line Items]        
Net sales $ 7,685 $ 6,886 $ 15,037 $ 13,530
Interest expense, net (119) (223) (255) (433)
Depreciation and amortization     (510) (497)
Stock-based compensation expense (29) (15) (52) (34)
Income before income taxes 235 359 526 697
Operating Segments        
Segment Reporting [Line Items]        
Segment adjusted EBITDA 1,271 1,091 2,223 2,103
Operating Segments | Medline Brand        
Segment Reporting [Line Items]        
Net sales 3,540 3,322 7,005 6,586
Segment adjusted EBITDA 1,067 890 1,832 1,720
Operating Segments | Supply Chain Solutions        
Segment Reporting [Line Items]        
Net sales 4,145 3,564 8,032 6,944
Segment adjusted EBITDA 204 201 391 383
Operating Segments | Front Line Care | Medline Brand        
Segment Reporting [Line Items]        
Net sales 1,652 1,592 3,270 3,118
Operating Segments | Surgical Solutions | Medline Brand        
Segment Reporting [Line Items]        
Net sales 1,640 1,509 3,194 2,956
Operating Segments | Laboratory and Diagnostics | Medline Brand        
Segment Reporting [Line Items]        
Net sales 248 221 541 512
Corporate & Other        
Segment Reporting [Line Items]        
Segment adjusted EBITDA (211) (156) (387) (300)
Reconciling Items        
Segment Reporting [Line Items]        
Interest expense, net (119) (223) (255) (433)
Depreciation and amortization (256) (250) (510) (497)
Inventory-related adjustments (3) (15) (32) (36)
Stock-based compensation expense (29) (15) (52) (37)
Litigation gains, net 0 13 0 47
Transaction-related costs (29) (11) (64) (23)
Other non-core charges, net $ (389) $ (75) $ (397) $ (127)